Studies on vaccinia hemagglutinin. IV. On the effect of nitrogen mustard on vaccinia hemagglutinin.

نویسندگان

  • I TAGAYA
  • A OTANI
  • M SUZUKI
چکیده

Many works were made on the biological application of mustard gas and nitrogen mustard. The mechanism of the biological action of mustards , however, remains largely unknown, and many experimental results have been accumulated to, suggest its mode of actions(1) , among which much attention has been called to the analogy of its action to those of X-ray irradiation or of hydrogen peroxide(2). Herriot(3) reported that mustard gas of nitrogen mustard inactivated plant, animal and bacterial viruses, bacteria , viruses, yeast, and pneumococcus type II transforming substance, and that those which contained more DNA were more readily inactivated . TenBroeck et al(4-6) pointed out that the antigenicity of mustard inactivated viruses was well preserved . Rose et al(7) and Fong et al(8-11) studied on the effect of mustards on influenza virus, and reported that the infectivity and toxicity were readily inactivated by mustards, whereas hemagglutiniating activity was most resistant . The fact reported by Burnet(12) that vaccinia hemagglutinin is a soluble substance which is distinct from the elementary body has been confirmed by many authors (13-16) , and the difference on hemagglutinin of MNI group virus from that of variolavaccinia-ectromelia group virus have been established . Tagaya(17) reported that a nitrogen mustard (methyl-bis-(beta-chroloethyl)amine hydrochloride) inactivated vaccinia hemagglutinin (to be referred subsequently as VH) at a concentration of 2.5 •~10-3M at 37•Ž for 2 hours , whereas its N-oxide synthesized by Ishidate et al(18) was inefective under the same conditions. Detailed works along the line have been carried out and the following

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Studies on an Inhibitor of Vaccinia Hemagglutinin*

The inhibitor of vaccinia hemagglutinin appearing in the ascites of the Ehrlich carcinoma of the mouse has been characterized and partially purified. The biological and chemical properties of this substance indicate that it has much in common with inhibitors reported previously in other biological material and suggest that, like these, it, too, is mucoprotein in nature. The inhibitor is found n...

متن کامل

Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.

We constructed recombinant vaccinia viruses (RVVs) that expressed human T-cell leukemia virus type I (HTLV-I) envelope glycoproteins by using attenuated vaccinia viruses (VVs) which have much lower neurovirulence than the WR strain that is extensively used as a vector. The RVV produced from the LC16mO strain, one of the attenuated VVs, elicited a high titer of anti-HTLV-I antibody in rabbits an...

متن کامل

Proflavine Inhibition of Vaccinia Virus Synthesis.

Bubel, H. Curt (University of Cincinnati College of Medicine, Cincinnati, Ohio), and David A. Wolff. Proflavine inhibition of vaccinia virus synthesis. J. Bacteriol. 89:977-983. 1965.-The synthesis of vaccinia virus, hemagglutinin, and blocking antigen, as well as the development of cytopathic effects, were inhibited by low concentrations of proflavine. This inhibitor did not exert a selective ...

متن کامل

Vaccinia virus hemagglutinin. A novel member of the immunoglobulin superfamily

Striking similarities between vaccinia virus hemagglutinin (VVHA) and proteins belonging to the Ig superfamily clearly indicate that VVHA, a 315-amino acid glycoprotein expressed on the surface of the infected cells, is a novel viral protein that can be added to the expanding list of the Ig superfamily. Its deduced amino acid sequence contains one Ig-like domain at the NH2 terminus, followed by...

متن کامل

A Recombinant Vaccinia Virus-based T Cell Vaccine against Influenza Virus Reduces Lung Viral Load upon Virus Challenge

Currently, there are only two approved vaccines against influenza virus, one containing killed virus and the other containing live, attenuated virus. Each year, there is a reformation of the vaccine formulation, depending on which strains are thought to become most dangerous in the upcoming season. Numerous groups and pharmaceutical companies are developing universal vaccines that would not req...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Japanese journal of medical science & biology

دوره 7 3  شماره 

صفحات  -

تاریخ انتشار 1954